Dyslipidemia Patterns in Adults with Congenital Heart Disease: Focus on HDL Cholesterol

Efrén Martínez-Quintana1,2, Fayna Rodríguez-González2,3

  • 1Cardiology Service, Complejo Hospitalario Universitario Insular-Materno Infantil, Avd. Marítima del Sur s/n, 35016 Las Palmas de Gran Canaria, Spain.

PubMed

Insights

Adults with congenital heart disease (CHD) have lower HDL cholesterol, especially those with complex conditions. A mixed pattern of low HDL and high LDL cholesterol was linked to arterial thrombosis in CHD patients.

Area of Science:

  • Cardiology
  • Lipidology
  • Vascular Biology

Background:

  • Improved survival in congenital heart disease (CHD) necessitates understanding modifiable cardiovascular risk factors.
  • Dyslipidemia in adult CHD patients is understudied, despite its importance.

Purpose of the Study:

  • To investigate the lipid profiles and arterial thrombosis events in adult patients with congenital heart disease.
  • To compare lipid parameters and thrombosis risk between CHD patients and matched controls.

Main Methods:

  • Retrospective study of 521 adult CHD patients and 1782 controls.
  • Cross-sectional assessment of lipid profiles (total cholesterol, LDL, HDL, triglycerides).
  • Recording of arterial thrombosis events over a mean follow-up of 5.8 years.

Main Results:

  • CHD patients showed significantly lower total cholesterol, LDL, HDL, and triglycerides compared to controls.
  • Low HDL cholesterol (<40 mg/dL) was more prevalent in CHD patients (20%) than controls (11.6%), increasing with CHD complexity.
  • Arterial thrombosis occurred more frequently in CHD patients (4.0%) versus controls (0.5%).

Conclusions:

  • Adult CHD patients present a distinct lipid profile characterized by lower HDL levels, particularly in complex cases.
  • While a mixed pattern of low HDL and high LDL was associated with thrombosis, this finding was not significant in multivariable analysis.
  • Further research is needed to clarify the role of dyslipidemia in cardiovascular events among adult CHD survivors.

Related Concept Videos

Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
534
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.2K
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
1.8K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
572
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
293